Wegovy 1.7 mg

Wegovy 1.7 mg – The Balance Point

Active ingredient: Semaglutide Dosage: 1.7 mg Treatment status: Optional maintenance dose / Pre-maximum stage. Estimated time: Fourth month (weeks 13-16 and beyond). Identification: Injection pen (color varies, often identified with shades of blue/turquoise in some markets).

No More "Just a Stop Along the Way"

Until now, every dosage was just a springboard to the next dosage. The 0.25, the 0.5, and even the 1.0 were mainly intended to acclimate the body. The 1.7 mg dosage is a different story. In the medical literature and clinical protocols, this dosage is already considered a very strong therapeutic dose. For a significant number of patients, this is the "final target" – the point where weight loss is satisfactory, and side effects are tolerable, without the need to escalate to the maximum dosage (2.4 mg).

This is the stage where the blood levels are high and stable enough to produce consistent weight loss over time, even as the initial excitement wanes.

Managing Scenarios: To Stay or To Advance?

By the fourth month of treatment, your body is already "talking" to you clearly. Instead of a regular table, we have prepared a Status Check to help you and your doctor decide what to do at the end of the 1.7 mg month:

Your Scenario What Does It Mean? Common Recommendation (for doctor consultation)
"I am losing weight excellently and feel good" You have found the "sweet spot." The body is responding well to the dosage, and you are not suffering. Stay at 1.7 mg. There is no need to rush to 2.4 mg if the current dosage is working excellently. Why fix what isn't broken?
"The weight loss has completely stopped (plateau)" The body has developed some tolerance to this dosage, and hunger is starting to return before the next injection. Consider increasing to 2.4 mg. This is the classic sign that the body needs a final push to continue the process.
"The side effects are unbearable" Nausea, vomiting, or extreme fatigue that affect quality of life and do not subside. Consider returning to 1.0 mg. Weight loss is not worth daily suffering. A lower dosage may be effective for a longer time.
"I can't eat anything" Excessive appetite suppression (Aversion). A dangerous condition that may lead to malnutrition. Stop or reduce dosage immediately. Consult a dietitian and doctor for readjustment.

"Advanced" Side Effects

At this stage (fourth month), the initial nausea often subsides, but side effects related to rapid weight loss, rather than the drug itself, may appear:

  1. Hair Loss (Telogen Effluvium): Many patients are alarmed by the amount of hair in the shower around months 3-4.

    • The good news: This is temporary. The body is under stress from weight loss and responds with shedding.

    • The solution: Blood tests (iron, B12, zinc) and obsessive adherence to protein. Hair will start to regrow as weight stabilizes.

  2. Loose Skin: When fat disappears quickly, the skin takes time to retract (if at all). Exercise that builds muscle ("toning") helps fill the volume left by the fat.

Tip for High-Dose Injection

As the dosage increases, the volume of fluid in the pen is slightly larger (though still minimal). At a dosage of 1.7 mg, it is very important to be diligent about rotating injection sites. Injecting into the same spot in the abdomen repeatedly can create a hard subcutaneous lump or scar tissue that will interfere with drug absorption in the future.

The Bottom Line

The 1.7 mg dosage is the real test. This is the stage where treatment transitions from "trial" to "lifestyle." From here, the path diverges: either you stay here for maintenance, or you ascend to the peak.


Important Note: This information should not be considered a substitute for individual medical advice. The decision to stay at 1.7 mg or increase to 2.4 mg is a medical decision based on your personal metrics.